Child Schizophrenia: Theory and Practice



Abstract Views
970

Downloads
600

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Feb 2, 2020
Published Feb 12, 2020
10.24018/ejmed.2020.2.1.160

Abstract viewed = 970 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Child schizophrenia is a mental disorder that affects brain structures, emotional and cognitive functions. The disorder is characterized by psychotic symptoms: disorder of thinking, inadequate emotional reactions, disorganized behavior, deterioration of social functioning and loss of will. Schizophrenia in children is one of the most common mental illnesses affecting up to 1% of all children. For a long time, the term "child schizophrenia" was used to refer to various disorders that had similarities with each other. Children were referred to schizophrenics if they had borderline symptoms. Child schizophrenia develops gradually; sudden onset it is not common. Schizophrenic child requires help from multidisciplinary team members including child and adolescent psychiatrist and all possible levels of psychotherapy and psychological interventions. This article discusses classification, clinical presentation, all possible treatment and rehabilitation of children with schizophrenia.

Keywords: child and adolescent psychiatry, schizophrenia, child schizophrenia, child depression, ADHD, antipsychotics

Downloads

Download data is not yet available.

References

  1. World Health Organization. (2018). Schizophrenia. Available at: https://www.who.int/news-room/fact-sheets/detail/schizophrenia (Accessed on 1st October, 2019).
     Google Scholar
  2. World Federation for Mental Health. (2014). Living a healthy life with schizophrenia: paving the road to recovery. Section V: Time to act. Available at: https://www.who.int/mental_health/world-mental-health-day/paper_wfmh.pdf (Accessed on 1st October, 2019).
     Google Scholar
  3. Remschmidt, H. E., Schulz, E., Martin, M., Warnke, A. & Trott, G. E. (1994). Childhood-Onset Schizophrenia: History of the Concept and Recent Studies. Schizophrenia Bulletin, 20(4): 727–745.
    DOI  |   Google Scholar
  4. American Psychiatric Association. (1980). DSM-III. Diagnostic and Statistical Manual of Mental Disorders (Third Edition): 2nd Printing edition.
     Google Scholar
  5. American Psychiatric Association. (1994). DSM-IV: Diagnostic and Statistical Manual of Mental Disorders: 4th Edition.
     Google Scholar
  6. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5(TM)): 5th Edition.
     Google Scholar
  7. World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines: 1st Edition.
     Google Scholar
  8. Phiri, C., Tsarkov, A., Petlovanyi, P., & Lingenda, G. Factors Contributing To Oral Diseases and Treatment Needs amongst Mental Patients at Chainama Hills College Hospital, Lusaka, Zambia. Available at: https://pdfs.semanticscholar.org/eb6c/a411d94f5adeb7f68fdaa3c728aad2038f85.pdf (Accessed on 10th October, 2019).
     Google Scholar
  9. D. Yu. Galaktionova, D. Y., Gareeva, A. E., Khusnutdinova, E. K. & Nasedkina, T, V. (2014). Association of SLC18A1, TPH1, and RELN gene polymorphisms with risk of paranoid schizophrenia. Molecular Biology, 48(4): 546–555.
    DOI  |   Google Scholar
  10. Haldeman-Englert, C. R. & Jewett, T. (2015). 1q21.1 Recurrent Microdeletion. GeneReviews® (Internet). Seattle (WA): University of Washington, Seattle; 1993-2019. Available at: https://www.ncbi.nlm.nih.gov/books/NBK52787/ (Accessed on 4th October, 2019).
     Google Scholar
  11. Steinberg, S., de Jong, S., Irish Schizophrenia Genomics Consortium, Andreassen, O. A., Werge, T., Børglum, A. D. & Stefansson, K. (2011). Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human molecular genetics, 20(20), 4076–4081. doi:10.1093/hmg/ddr325.
    DOI  |   Google Scholar
  12. McTigue, O., & O'Callaghan, E. (2000). Season of Birth as a Risk Factor. International Journal of Mental Health, 29(3), 66-78.
    DOI  |   Google Scholar
  13. Boksa P. (2008). Maternal infection during pregnancy and schizophrenia. Journal of psychiatry & neuroscience: JPN, 33(3), 183–185.
     Google Scholar
  14. Yüksel, R. N., Altunsoy, N., Tikir, B., Cingi Külük, M., Unal, K., Goka, S., … Goka, E. (2014). Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Therapeutic advances in psychopharmacology, 4(6), 268–275.
    DOI  |   Google Scholar
  15. McGrath, J., Brown, A., & St Clair, D. (2011). Prevention and schizophrenia--the role of dietary factors. Schizophrenia bulletin, 37(2), 272–283.
    DOI  |   Google Scholar
  16. Tsarkov, A., & Petlovanyi, P. (2017). Omega-3 Fatty Acids as an Alternative Treatment for Children with Attention Deficit Hyperactivity Disorder. Imperial Journal of Interdisciplinary Research (IJIR), 3, 1378-1380. Available at: https://pdfs.semanticscholar.org/42bd/c75304c050d502670c7e8c86fddf5f5079ce.pdf (Accessed on 12th October, 2019).
     Google Scholar
  17. Nagler, S. & Mirsky, A. F. (1985). Introduction: The Israeli High-Risk Study. Schizophr Bull., 11(1): 19-29.
    DOI  |   Google Scholar
  18. Davidsen, K. A., Harder, S., MacBeth, A., Lundy, J. M., & Gumley, A. (2015). Mother-infant interaction in schizophrenia: transmitting risk or resilience? A systematic review of the literature. Social psychiatry and psychiatric epidemiology, 50(12): 1785–1798.
    DOI  |   Google Scholar
  19. Tsarkov, A., & Petlovanyi, P. (2019). Neuropsychiatric Aspects of a Common Problem: Stroke. European Journal of Medical and Health Sciences, 1(3). https://doi.org/10.24018/ejmed.2019.1.3.64 Available at: https://pdfs.semanticscholar.org/e830/852f04b7b788300b6f23f295e10327c858e5.pdf (Accessed on 12th October, 2019).
     Google Scholar
  20. Li M. (2016). Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms. Journal of psychopharmacology, 30(8): 749–770.
    DOI  |   Google Scholar
  21. Tsarkov, A., & Petlovanyi, P. The Role of Lamotrigine in the Treatment of Bipolar Depression. Available at: https://pdfs.semanticscholar.org/bd92/bbbe8a986a155e0684fd6f27569ebd895d6e.pdf (Accessed on 10th October, 2019).
     Google Scholar
  22. Reyes, M., Croonenberghs, J., Augustyns, I. & Eerdekens, M. (2006). Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability. J. Child Adolesc. Psychopharmacol., 16(3): 260-272.
    DOI  |   Google Scholar
  23. Food and Drug Administration. (2015). Atypical Antipsychotic Medications: Use in Pediatric Patients. Available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Pharmacy-Education-Materials/Downloads/atyp-antipsych-pediatric-factsheet11-14.pdf (Accessed on 9th October, 2019).
     Google Scholar
  24. Tsarkov, A., & Petlovanyi, P. (2016). Bipolar Disorder in Child Psychiatric Practice: A Case Report. Medical Journal of Zambia, 43(1), 41-46. Available at: https://www.ajol.info/index.php/mjz/article/viewFile/142808/132555 (Accessed on 9th October, 2019).
     Google Scholar
  25. Tsarkov, A., & Petlovanyi, P. Depressive Disorder in Child Psychiatric Practice: A. The Health Press, 9. Available at: http://znphi.co.zm/thehealthpress/wp-content/uploads/2017/09/THPZ_V1_I5_May_final.3.pdf (Accessed on 10th October, 2019).
     Google Scholar


Most read articles by the same author(s)